Skip to main content
Laura Graham, MD, Oncology, Aurora, CO

Laura Simons Graham MD


Physician

Join to view full profile
  • 1665 Aurora CtAurora, CO 80045

  • Phone+1 720-848-0000

Dr. Graham is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Laura Graham is an oncologist based in Aurora, CO. She completed her medical degree at Rush Medical College in 2015, followed by a residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at the University of Washington. Her expertise extends to prostate, kidney, testicular, and urinary tract cancers. Her research includes publications on hormone-sensitive prostate cancer, urinary cancer susceptibility, and prostate cancer systems biology. She is an inductee of the Alpha Omega Alpha Honor Medical Society.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2018 - 2021
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2015 - 2018
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 2015
  • University of Chicago
    University of ChicagoBA, Biological Sciences, 2005 - 2009

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2021 - 2027
  • WA State Medical License
    WA State Medical License 2015 - 2022
  • ID State Medical License
    ID State Medical License 2017 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

Lectures

  • Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative trial in high risk localized prostate cancer (PC). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Clinical Trials of Potentially ‘Game-Changing’ Immunotherapy Drug for Advanced Prostate Cancer Underway at CU Anschutz Cancer Center
    Clinical Trials of Potentially ‘Game-Changing’ Immunotherapy Drug for Advanced Prostate Cancer Underway at CU Anschutz Cancer CenterSeptember 1st, 2026
  • Onsite Genetic Testing Leads to Better Testing Rates for Colorado Patients with Prostate Cancer
    Onsite Genetic Testing Leads to Better Testing Rates for Colorado Patients with Prostate CancerJuly 23rd, 2026
  • Cancer Clinical Trials Go Remote, Improving Access and Accrual
    Cancer Clinical Trials Go Remote, Improving Access and AccrualOctober 3rd, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: